Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Price Reaction to Earnings Reports

View detailed tables showing price action before and after earnings announcements, ranging from intraday to one week out. Track how the market has reacted to past earnings to identify patterns and predict future behavior. Click here to open.

CYRX

CryoPort Inc

Dec 24 • 04:00PM ET

7.87

Dollar change +0.18
Percentage change 2.34	%

Industrials • Integrated Freight & Logistics • USA • NASD

Peers: TMO DHR BDX CTLT STE BRKR BIO AVTR ADPT ICUI

| Held by: VTI IWM VXF IWO SCHA VTWO VHT DFAS DFAT IWN

Scroll to Statements

Index	RUT	P/E	-	EPS (ttm)	-3.39	Insider Own	3.72%	Shs Outstand	49.43M	Perf Week	-3.32%
Market Cap	389.02M	Forward P/E	-	EPS next Y	-1.03	Insider Trans	-11.30%	Shs Float	47.59M	Perf Month	19.97%
Income	-166.47M	PEG	-	EPS next Q	-0.29	Inst Own	95.50%	Short Float	4.62%	Perf Quarter	-0.76%
Sales	226.11M	P/S	1.72	EPS this Y	-7.16%	Inst Trans	-5.48%	Short Ratio	5.32	Perf Half Y	10.85%
Book/sh	7.81	P/B	1.01	EPS next Y	56.46%	ROA	-18.62%	Short Interest	2.20M	Perf Year	-51.09%
Cash/sh	5.52	P/C	1.43	EPS next 5Y	-	ROE	-33.15%	52W Range	5.32 - 20.10	Perf YTD	-49.19%
Dividend Est.	-	P/FCF	-	EPS past 5Y	-45.48%	ROI	-26.37%	52W High	-60.86%	Beta	1.61
Dividend TTM	-	Quick Ratio	5.32	Sales past 5Y	78.51%	Gross Margin	34.51%	52W Low	48.07%	ATR (14)	0.58
Dividend Ex-Date	-	Current Ratio	5.70	EPS Y/Y TTM	-201.68%	Oper. Margin	-31.65%	RSI (14)	53.90	Volatility	7.69% 8.16%
Employees	1170	Debt/Eq	0.56	Sales Y/Y TTM	-4.33%	Profit Margin	-73.62%	Recom	2.20	Target Price	10.89
Option/Short	Yes / Yes	LT Debt/Eq	0.51	EPS Q/Q	92.25%	Payout	-	Rel Volume	0.22	Prev Close	7.69
Sales Surprise	-2.40%	EPS Surprise	93.53%	Sales Q/Q	0.90%	Earnings	Nov 07 AMC	Avg Volume	413.25K	Price	7.87
SMA20	2.29%	SMA50	6.12%	SMA200	-22.48%	Trades		Volume	90,755	Change	2.34%

Date	Action	Analyst	Rating Change	Price Target Change
Dec-19-24	Initiated	Guggenheim	Buy	$11
Aug-07-24	Downgrade	Jefferies	Buy → Hold	$20 → $8
Jul-31-24	Upgrade	B. Riley Securities	Neutral → Buy	$19 → $15
May-03-24	Downgrade	B. Riley Securities	Buy → Neutral	$22 → $19
Apr-04-24	Resumed	Jefferies	Buy	$17 → $21
Mar-13-24	Reiterated	Needham	Buy	$19 → $18
Aug-17-23	Initiated	Morgan Stanley	Equal-Weight	$16
Aug-10-23	Downgrade	Stephens	Overweight → Equal-Weight	$15
Jul-18-23	Downgrade	UBS	Buy → Neutral	$28 → $17
Jul-17-23	Downgrade	KeyBanc Capital Markets	Overweight → Sector Weight
Jul-13-23	Downgrade	SVB Securities	Outperform → Market Perform	$30 → $10
Jan-19-22	Upgrade	ROTH Capital	Neutral → Buy	$90
Nov-05-21	Downgrade	ROTH Capital	Buy → Neutral	$78 → $90
Oct-19-21	Resumed	B. Riley Securities	Buy	$81
Jul-16-21	Initiated	BTIG Research	Buy	$80
Mar-15-21	Initiated	UBS	Buy	$84
Mar-02-21	Resumed	Needham	Buy	$73
Nov-10-20	Initiated	KeyBanc Capital Markets	Overweight	$54
Jan-08-20	Initiated	Stephens	Overweight	$21
Jul-01-19	Resumed	Needham	Buy	$22

Show Previous Ratings

Nov-12-24 08:30AM	Cryoport Expands IntegriCell Cryopreservation Services Solution with Opening of New Center of Excellence in Europe (PR Newswire)
Nov-08-24 04:03PM	CryoPort Inc (CYRX) Q3 2024 Earnings Call Highlights: Strong Service Growth Amid Market Challenges (GuruFocus.com)
Nov-07-24 05:55PM	CryoPort, Inc. (CYRX) Reports Q3 Loss, Misses Revenue Estimates (Zacks)
04:05PM	Cryoport Reports Third Quarter 2024 Financial Results (PR Newswire)
Nov-06-24 07:37AM	CryoPort Inc (CYRX) Q3 2024: Everything You Need to Know Ahead of Earnings (GuruFocus.com)
10:01AM	Loading…
Oct-31-24 10:01AM	CryoPort, Inc. (CYRX) Expected to Beat Earnings Estimates: Can the Stock Move Higher? (Zacks)
Oct-29-24 08:30AM	Cryoport to Report Third Quarter 2024 Financial Results on November 7, 2024 (PR Newswire)
Oct-22-24 08:30AM	Cryoport and Gulf Coast Regional Blood Center Launch Strategic Alliance to Enhance Cellular Therapy Services (PR Newswire)
Oct-21-24 08:30AM	TMRW Life Sciences and Cryoport Systems Form Strategic Partnership to Elevate Standards for Frozen Egg, Embryo, and Sperm Offsite Storage and Biologistics (PR Newswire)
Oct-15-24 08:30AM	VGXI Selects Cryoport for Biostorage, Bioservices and Supply Chain Solutions to Advance Next-Generation Therapies (PR Newswire)
Oct-07-24 08:30AM	Cryoport Launches its IntegriCell Cryopreservation Solution with Opening of New Facility at its Houston Campus (PR Newswire)
Sep-25-24 08:30AM	SK pharmteco and Cryoport Partner for Cell and Gene Therapy Logistics and BioServices (PR Newswire)
Sep-09-24 05:28AM	Should You Hold Cryoport (CYRX)? (Insider Monkey) -5.75%
Aug-19-24 03:27AM	Should You be Optimistic on the Growth Prospects of CryoPort (CYRX)? (Insider Monkey)
Aug-06-24 07:00PM	CryoPort, Inc. (CYRX) Reports Q2 Loss, Lags Revenue Estimates (Zacks)
04:15PM	Loading…
04:15PM	Cryoport Reports Second Quarter 2024 Financial Results (PR Newswire)
04:05PM	Cryoport Announces $200 Million Repurchase Program and the Repurchase of $160 Million of Convertible Senior Notes (PR Newswire)
Jul-23-24 08:30AM	Cryoport to Report Second Quarter 2024 Financial Results on August 6, 2024 (PR Newswire) -5.54%
Jul-12-24 02:46AM	CryoPort (CYRX) Moves 26.7% Higher: Will This Strength Last? (Zacks)
Jul-09-24 09:35AM	CryoPort (CYRX) Loses -43.56% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner (Zacks) -5.51%
Jun-20-24 08:30AM	Cryoport and Minaris Regenerative Medicine Form Strategic Partnership to Support Advancement of Cell and Gene Therapies (PR Newswire)
May-17-24 02:33AM	Insider Sale: Director Richard Berman Sells 8,105 Shares of CryoPort Inc (CYRX) (GuruFocus.com) -7.39%
May-08-24 02:54PM	Cryoport, Inc. (NASDAQ:CYRX) Q1 2024 Earnings Call Transcript (Insider Monkey) -19.51%
04:03AM	CryoPort Inc (CYRX) Q1 2024 Earnings Call Transcript Highlights: Navigating Challenges with ... (GuruFocus.com)
May-07-24 09:56PM	CYRX Stock Earnings: CryoPort Misses EPS, Misses Revenue for Q1 2024 (InvestorPlace)
06:18PM	CryoPort Inc (CYRX) Q1 2024 Earnings: Revenue Declines Amid Challenges, Yet Maintains Full-Year ... (GuruFocus.com)
04:08PM	Cryoport Reports First Quarter 2024 Financial Results (PR Newswire)
May-03-24 10:12AM	B. Riley Downgrades Cryoport to Neutral From Buy, Adjusts Price Target to $19 From $22 (MT Newswires) -7.05%
06:41AM	B. Riley Downgrades Cryoport to Neutral From Buy, Cuts Price Target to $19 From $22 (MT Newswires)
Apr-30-24 08:30AM	Cryoport to Report First Quarter 2024 Financial Results on May 7, 2024 (PR Newswire)
10:02AM	Loading…
Apr-25-24 10:02AM	Earnings Preview: CryoPort, Inc. (CYRX) Q1 Earnings Expected to Decline (Zacks)
Mar-13-24 09:16AM	Cryoport, Inc. (NASDAQ:CYRX) Q4 2023 Earnings Call Transcript (Insider Monkey) -11.90%
Mar-12-24 05:52PM	CryoPort Inc (CYRX) Reports Mixed Financial Results Amidst Global Challenges (GuruFocus.com)
05:30PM	CryoPort, Inc. (CYRX) Reports Q4 Loss, Misses Revenue Estimates (Zacks)
04:05PM	Cryoport Reports Fourth Quarter and Full Year 2023 Financial Results (PR Newswire)
Feb-27-24 08:30AM	Cryoport to Report Fourth Quarter and Full Year 2023 Financial Results on March 12, 2024 (PR Newswire) +5.95%
Feb-15-24 10:00AM	Analysts Estimate CryoPort, Inc. (CYRX) to Report a Decline in Earnings: What to Look Out for (Zacks)
Feb-13-24 09:55AM	Should You Buy CryoPort, Inc. (CYRX) After Golden Cross? (Zacks) -8.87%
Nov-27-23 08:30AM	Cryoport and NIPPON EXPRESS HOLDINGS Form Global Strategic Partnership for Temperature-Controlled Supply Chain Services (PR Newswire)
Nov-21-23 03:26PM	Consultant's Insight: Cryoport expands its cold-chain supply chain capabilities (Air Cargo World)
Nov-16-23 08:30AM	Cryoport's CRYOPDP Expands U.S. Footprint with Acquisition of Bluebird Express (PR Newswire)
Nov-09-23 05:23PM	Cryoport, Inc. (NASDAQ:CYRX) Q3 2023 Earnings Call Transcript (Insider Monkey) +10.03%
Nov-08-23 06:05PM	CryoPort Inc (CYRX) Faces Economic Headwinds but Sees Growth in Key Segments (GuruFocus.com)
04:05PM	Cryoport Reports Third Quarter 2023 Financial Results (PR Newswire)
Nov-02-23 08:30AM	Cryoport Continues its Expansion in the European Market with Tec4med Lifescience GmbH Acquisition (PR Newswire)
Oct-26-23 10:02AM	Analysts Estimate CryoPort, Inc. (CYRX) to Report a Decline in Earnings: What to Look Out for (Zacks)
Oct-25-23 08:30AM	Cryoport to Report Third Quarter 2023 Financial Results on November 8, 2023 (PR Newswire) -6.36%
Oct-12-23 08:30AM	Cryoport Inks New Multi-Year Supply Chain Solutions Agreement with Monash IVF (PR Newswire)
Oct-10-23 08:30AM	Cryoport and Cell and Gene Therapy Catapult Announce Strategic Collaboration at Stevenage Manufacturing Innovation Centre for Advancement of Cell and Gene Therapies (PR Newswire) +5.19%
Oct-09-23 04:05PM	Be The Match BioTherapies and Cryoport Partner to Accelerate the Development of Cell and Gene Therapies (PR Newswire)
Sep-14-23 08:30AM	Cryoport Receives 2023 IMAPAC Asia Pacific Cell & Gene Therapy Excellence Award (PR Newswire)
Aug-10-23 07:14AM	Cryoport (CYRX) Fell 28.1% in Q2 Despite Beating Earnings Expectations (Insider Monkey)
Aug-09-23 05:30PM	CryoPort, Inc. (CYRX) Reports Q2 Loss, Tops Revenue Estimates (Zacks)
04:05PM	Cryoport Reports Second Quarter 2023 Financial Results (PR Newswire)
Aug-02-23 08:30AM	Cryoport to Report Second Quarter 2023 Financial Results on August 9, 2023 (PR Newswire)
Jul-31-23 08:53AM	Heres Why Cryoport (CYRX) Declined in Q2 (Insider Monkey)
Jul-23-23 08:17AM	Cryoport, Inc. (NASDAQ:CYRX) Analysts Just Cut Their EPS Forecasts Substantially (Simply Wall St.)
Jul-13-23 12:24PM	Trade Desk, MillerKnoll rise; CryoPort, Fastenal fall, Thursday, 7/13/2023 (AP Finance) -24.74%
11:17AM	Why Shares of Cryoport are Tumbling Thursday (Motley Fool)
Jul-12-23 04:05PM	Cryoport Announces Certain Preliminary Results for Second Quarter & Updates 2023 Revenue Expectations (PR Newswire)
12:56PM	Cryoport cuts FY guidance as Q2 revenue hurt by weaker demand; Shares sink (Investing.com)
Jun-29-23 08:39AM	IVFAustralia Selects Cryoport as Exclusive Supply Chain Solutions Provider (PR Newswire)
May-25-23 08:02AM	CryoPort (CYRX) Rose on Revenue Guidance (Insider Monkey)
May-12-23 07:15AM	Cryoport, Inc. (NASDAQ:CYRX) Screens Well But There Might Be A Catch (Simply Wall St.) -7.86%
May-04-23 06:05PM	CryoPort, Inc. (CYRX) Reports Q1 Loss, Tops Revenue Estimates (Zacks) +13.71%
04:05PM	Cryoport Reports First Quarter 2023 Results (PR Newswire)
Apr-27-23 10:02AM	Will CryoPort, Inc. (CYRX) Report Negative Q1 Earnings? What You Should Know (Zacks)
08:30AM	Cryoport to Report First Quarter 2023 Financial Results on May 4, 2023 (PR Newswire)
Apr-25-23 08:30AM	Cryoport Signs New Supply Chain Solutions Agreement with Boston IVF to Support Reproductive Material Shipments Across the U.S. (PR Newswire) -6.78%
Apr-01-23 08:54AM	Cryoport, Inc.'s (NASDAQ:CYRX) Intrinsic Value Is Potentially 94% Above Its Share Price (Simply Wall St.)
Mar-28-23 08:30AM	Cryoport Announces Multi-Year Agreement with Inception Fertility (PR Newswire)
Mar-16-23 03:46AM	Macroeconomic Headwinds Dragged Cryoport (CYRX) in Q4 (Insider Monkey) +8.28%
Mar-13-23 06:00AM	Cryoport Confirms No Financial Exposure to Silicon Valley Bank (PR Newswire)
Mar-08-23 01:15PM	Cell Therapy Has Shown Near Miraculous Remission Rates In Cancer Patients, But The Growing Industry Relies On This Company A Uniquely Positioned Ticker In The Weeds? (News Direct)
Feb-23-23 06:40PM	CryoPort, Inc. (CYRX) Reports Q4 Loss, Tops Revenue Estimates (Zacks) +8.79%
04:05PM	Cryoport Reports Fourth Quarter and Full Year 2022 Results (PR Newswire)
Feb-15-23 08:30AM	Cryoport to Report Fourth Quarter and Full Year 2022 Financial Results on February 23, 2023 (PR Newswire) +6.85%
Jan-29-23 07:31AM	When Will Cryoport, Inc. (NASDAQ:CYRX) Become Profitable? (Simply Wall St.)
Jan-26-23 10:55AM	Syneos Health (SYNH) Signs New Partnership With Cryoport (Zacks)
Jan-18-23 08:30AM	Cryoport Announces New Strategic Partnership with Syneos Health to Advance Cell & Gene Therapies (PR Newswire)
Dec-20-22 08:30AM	Cryoport to Present at the J.P. Morgan 41st Annual Healthcare Conference (PR Newswire)
Dec-19-22 07:15AM	Cryoport (NASDAQ:CYRX) shareholders have earned a 15% CAGR over the last five years (Simply Wall St.) -5.30%
Nov-08-22 06:56AM	Cryoport Third Quarter 2022 Earnings: Misses Expectations (Simply Wall St.)
Nov-07-22 08:10PM	Time to Bottom Fish? 2 Strong Buy Stocks That Are Down 70% This Year (TipRanks)
05:03AM	Some Cryoport, Inc. (NASDAQ:CYRX) Analysts Just Made A Major Cut To Next Year's Estimates (Simply Wall St.)
Nov-03-22 06:45PM	CryoPort, Inc. (CYRX) Reports Q3 Loss, Misses Revenue Estimates (Zacks) -32.05%
04:05PM	Cryoport Reports Results for the Third Quarter 2022 (PR Newswire)
Oct-27-22 08:30AM	Cryoport to Report Third Quarter 2022 Financial Results on November 3, 2022 (PR Newswire)
05:32AM	CryoPort, Inc. (CYRX) Stock Jumps 10.5%: Will It Continue to Soar? (Zacks)
Sep-08-22 08:30AM	Cryoport Enters into Strategic Relationship with Takeda's BioLife Plasma Services (PR Newswire)
Aug-08-22 02:42PM	Cryoport Stock Shows Market Leadership With Jump To 91 RS Rating (Investor's Business Daily) +6.83%
Aug-06-22 10:18AM	Cryoport, Inc.'s (NASDAQ:CYRX) Profit Outlook (Simply Wall St.)
Aug-05-22 09:55AM	Can CryoPort, Inc. (CYRX) Climb 36% to Reach the Level Wall Street Analysts Expect? (Zacks) +6.69%
Aug-04-22 07:15PM	CryoPort, Inc. (CYRX) Reports Q2 Loss, Lags Revenue Estimates (Zacks)
04:05PM	Cryoport Reports Results for the Second Quarter 2022 (PR Newswire)
Jul-28-22 08:30AM	Cryoport to Report Second Quarter 2022 Financial Results on August 4, 2022 (PR Newswire)
Jul-01-22 08:57AM	Cryoport's (NASDAQ:CYRX) growing losses don't faze investors as the stock ascends 4.2% this past week (Simply Wall St.)
May-05-22 07:05PM	CryoPort, Inc. (CYRX) Reports Q1 Loss, Tops Revenue Estimates (Zacks) -6.97%
04:05PM	Cryoport Reports First Quarter 2022 Results (PR Newswire)
Apr-28-22 08:30AM	Cryoport to Report First Quarter 2022 Financial Results on May 5, 2022 (PR Newswire)

CryoPort, Inc. engages in the provision of logistics solutions to the life science industry. It also provides logistics solutions for biologic materials such as immunotherapies, stem cells, CAR-T cells, and reproductive cells for clients worldwide, including points-of-care, clinical research organizations central laboratories, biopharmaceuticals, contract manufacturing, health centers, and university researchers. It offers personalized medicine, immunotherapies, cellular therapies, CAR T-cell therapies, stem cell therapies, vaccines, diagnostic materials, semen, eggs, embryos, cord blood, bio-pharmaceuticals, infectious substances, and other commodities that require continuous exposure to certain ranges of precision-controlled temperatures. The company was founded on May 25, 1990 and is headquartered in Brentwood, TN.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
STEFANOVICH ROBERT	Chief Financial Officer	Dec 11 '24	Option Exercise	4.80	53,334	256,003	181,667	Dec 13 06:13 PM
Mandalam Ramkumar	Director	Dec 02 '24	Option Exercise	4.80	10,834	52,003	66,866	Dec 04 07:00 PM
Mandalam Ramkumar	Director	Dec 02 '24	Sale	7.46	7,369	54,978	59,497	Dec 04 07:00 PM
Hariri Robert J	Director	Nov 21 '24	Sale	6.48	2,500	16,200	20,561	Dec 02 07:00 PM
RAMKUMAR MANDALAM	Director	Dec 02 '24	Proposed Sale	7.08	7,369	52,173		Dec 02 04:43 PM
SHELTON JERRELL	President, CEO	Nov 21 '24	Option Exercise	4.80	59,150	283,920	781,897	Nov 25 07:00 PM
SHELTON JERRELL	President, CEO	Nov 22 '24	Option Exercise	4.80	26,862	128,938	758,759	Nov 25 07:00 PM
SHELTON JERRELL	President, CEO	Nov 21 '24	Sale	6.51	50,000	325,275	731,897	Nov 25 07:00 PM
SHELTON JERRELL	President, CEO	Nov 22 '24	Sale	6.47	22,817	147,612	735,942	Nov 25 07:00 PM
JERRELL W SHELTON	Director	Nov 22 '24	Proposed Sale	6.52	22,817	148,767		Nov 22 04:31 PM
SHELTON JERRELL	President, CEO	Nov 19 '24	Option Exercise	4.80	60,440	290,112	762,747	Nov 20 07:57 PM
SHELTON JERRELL	President, CEO	Nov 18 '24	Option Exercise	4.80	60,215	289,032	752,307	Nov 20 07:57 PM
SHELTON JERRELL	President, CEO	Nov 20 '24	Option Exercise	4.80	60,000	288,000	772,747	Nov 20 07:57 PM
SHELTON JERRELL	President, CEO	Nov 19 '24	Sale	6.78	50,000	338,985	712,747	Nov 20 07:57 PM
SHELTON JERRELL	President, CEO	Nov 18 '24	Sale	6.73	50,000	336,540	702,307	Nov 20 07:57 PM
SHELTON JERRELL	President, CEO	Nov 20 '24	Sale	6.65	50,000	332,295	722,747	Nov 20 07:57 PM
JERRELL W SHELTON	Director	Nov 20 '24	Proposed Sale	6.93	100,000	693,500		Nov 20 04:33 PM
JERRELL W SHELTON	Director	Nov 19 '24	Proposed Sale	6.70	50,000	335,000		Nov 19 04:30 PM
JERRELL W SHELTON	Director	Nov 18 '24	Proposed Sale	6.99	50,000	349,500		Nov 18 05:14 PM
Hariri Robert J	Director	Aug 19 '24	Sale	9.46	1,000	9,465	23,061	Aug 26 07:11 PM
Hariri Robert J	Director	Aug 16 '24	Sale	9.00	1,000	9,000	23,561	Aug 20 05:28 PM
Hariri Robert J	Director	Aug 14 '24	Sale	8.40	1,000	8,395	24,561	Aug 20 05:28 PM
Mandalam Ramkumar	Director	Aug 02 '24	Option Exercise	5.04	4,167	21,002	60,199	Aug 06 08:00 PM
Mandalam Ramkumar	Director	Aug 02 '24	Sale	8.04	4,167	33,520	56,032	Aug 06 08:00 PM
RAMKUMAR MANDALAM	Director	Aug 02 '24	Proposed Sale	8.70	4,167	36,253		Aug 02 04:22 PM
BERMAN RICHARD J	Director	May 15 '24	Sale	13.41	8,105	108,693	100,000	May 16 05:30 PM
ZECCHINI EDWARD J	Chief Digital and Tech Officer	May 14 '24	Sale	13.37	3,443	46,042	60,051	May 15 07:28 PM
STEFANOVICH ROBERT	Chief Financial Officer	Mar 25 '24	Sale	17.54	1,079	18,928	128,333	Mar 26 08:12 PM
SHELTON JERRELL	Chief Executive Officer	Mar 25 '24	Sale	17.54	2,631	46,154	692,182	Mar 26 08:09 PM
Sawicki Mark W	Chief Scientific Officer	Mar 25 '24	Sale	17.54	1,367	23,980	77,444	Mar 26 08:08 PM
STEFANOVICH ROBERT	Chief Financial Officer	Mar 09 '24	Option Exercise	0.00	2,666	0	125,816	Mar 19 07:51 PM
STEFANOVICH ROBERT	Chief Financial Officer	Mar 11 '24	Sale	16.35	1,119	18,298	124,697	Mar 19 07:51 PM
STEFANOVICH ROBERT	Chief Financial Officer	Mar 15 '24	Sale	15.43	1,035	15,972	123,662	Mar 19 07:51 PM
Sawicki Mark W	Chief Scientific Officer	Mar 09 '24	Option Exercise	0.00	2,666	0	75,791	Mar 19 07:50 PM
Sawicki Mark W	Chief Scientific Officer	Mar 11 '24	Sale	16.35	1,418	23,188	74,373	Mar 19 07:50 PM
Sawicki Mark W	Chief Scientific Officer	Mar 15 '24	Sale	15.43	1,312	20,247	73,061	Mar 19 07:50 PM
Mandalam Ramkumar	Director	Mar 15 '24	Option Exercise	5.40	8,334	45,004	46,404	Mar 19 07:49 PM
Mandalam Ramkumar	Director	Mar 15 '24	Sale	14.68	3,217	47,226	43,187	Mar 19 07:49 PM
BADDOUR LINDA	Director	Mar 15 '24	Option Exercise	0.00	1,111	0	21,690	Mar 19 07:48 PM
SHELTON JERRELL	President, CEO	Mar 15 '24	Option Exercise	4.80	100,000	480,000	749,253	Mar 19 07:48 PM
SHELTON JERRELL	President, CEO	Mar 09 '24	Option Exercise	0.00	8,250	0	640,674	Mar 19 07:48 PM
SHELTON JERRELL	President, CEO	Mar 15 '24	Sale	15.30	57,039	872,884	634,352	Mar 19 07:48 PM
SHELTON JERRELL	President, CEO	Mar 11 '24	Sale	16.35	3,723	60,880	636,951	Mar 19 07:48 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

CYRX

CryoPort Inc

Upgrade your FINVIZ experience